Language selection

Search

Patent 2865584 Summary

Third-party information liability

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Claims and Abstract availability

Any discrepancies in the text and image of the Claims and Abstract are due to differing posting times. Text of the Claims and Abstract are posted:

  • At the time the application is open to public inspection;
  • At the time of issue of the patent (grant).
(12) Patent Application: (11) CA 2865584
(54) English Title: FORMALIN-FREE FIXATION AGENT FOR HISTOLOGICAL STAINS OF TISSUE SAMPLES
(54) French Title: AGENT DE FIXATION EXEMPT DE FORMOL POUR LA COLORATION HISTOLOGIQUE D'ECHANTILLONS DE TISSUS
Status: Dead
Bibliographic Data
(51) International Patent Classification (IPC):
  • G01N 1/30 (2006.01)
(72) Inventors :
  • GERIGK, ROBERTO (Germany)
  • GUDO, MICHAEL (Germany)
(73) Owners :
  • GERIGK, ROBERTO (Germany)
(71) Applicants :
  • GERIGK, ROBERTO (Germany)
(74) Agent: BENOIT & COTE INC.
(74) Associate agent:
(45) Issued:
(86) PCT Filing Date: 2013-03-01
(87) Open to Public Inspection: 2013-09-12
Availability of licence: N/A
(25) Language of filing: English

Patent Cooperation Treaty (PCT): Yes
(86) PCT Filing Number: PCT/EP2013/054146
(87) International Publication Number: WO2013/131816
(85) National Entry: 2014-08-26

(30) Application Priority Data:
Application No. Country/Territory Date
10 2012 101 896.0 Germany 2012-03-06

Abstracts

English Abstract

The invention relates to the development of a fixation solution which effects a clear improvement of the known histological and immunological staining techniques as well as the staining techniques used in pathology. In particular, the present invention improves the quality and staining of tissue samples or tissue sections that have not been fixed with formalin. The present invention is especially advantageous for sensitive tissue that is difficult to cut when fixed with formalin, which can not only be cut with a better quality without artefacts, but also has a higher brilliance and colour stability of the stain.


French Abstract

L'invention concerne un développement d'une solution de fixation qui conditionne une nette amélioration des techniques connues de coloration histologique et immunologique ainsi que des techniques de coloration utilisées en pathologie. En particulier, la présente invention améliore la qualité et la coloration d'échantillons, respectivement de coupes de tissus qui n'ont pas été fixés au formol. La présente invention se révèle particulièrement avantageuse pour des tissus sensibles difficiles à couper en cas de fixation au formol, que non seulement on peut couper en une meilleure qualité sans artéfacts, mais qui présentent également dans leur coloration une plus grande brillance et une plus grande stabilité de couleur.

Claims

Note: Claims are shown in the official language in which they were submitted.


- 39 -
CLAIMS
(1) A fixation agent for tissue samples, containing
- at least one
polyamine, selected from the group
consisting of urotropine, triazines, dimethylol
dihydroxyethylene urea, mono-, di-, tri-, tetra-,
penta- or hexamethylol melamine, tetramethylol
acetylene diurea, dimethylol propylene urea,
acetoguanamine or 5,5-dimethylhydantoin, and
mixtures thereof, and
- at least one
acidification agent selected from
the group of free monovalent, bivalent or
polyvalent acid consisting of oxalic acid,
fumaric acid, tartaric acid, maleic acid,
succinic acid, hydrochloric acid, acetic acid,
propionic acid, formic acid, mono-, di- or tri
chloroacetic acid or chloroacetic acid, boric
acid, phosphoric acid, and mixtures thereof,
characterised in that
the polyamine reacts with the protons released from
the acid, thus forming or releasing aldehydes, and the
molar ratio between the molar concentration of
releasable aldehyde per mol of polyamine to the molar
concentration of releasable protons per mol of acid
lies in a range from 1:0.7 to 1:1.5.
(2) The fixation agents according to Claim 1,
characterised in that the fixation agent comprises at
least one further polyfunctional aldehyde selected
from the group consisting of citral, 3,7-dimethylocta-
2,6-dienal, geranial, (E)-3,7-dimethylocta-2,6-dienal,
propanal, butanal, valeric aldehyde, pentanal,
hexanal, heptanal, octanal, nonanal, decanal, (2 E)-3-
phenylprop-2-enal, benzaldehyde,
phenylmethanal,

- 40 -
vanillin aldehyde, 4-hydroxy-3-methoxyphenylmethanal,
and mixtures thereof.
(3) The fixation agent according to Claim 1 or 2,
characterised in that the molar concentration of the
total available aldehyde in the solution is at least
0.5 mol/l.
(4) The fixation agent according to one of the preceding
claims, characterised in that it is present in aqueous
solution.
(5) The fixation agent according to one of the preceding
claims, characterised in that it is set to a pH range
of 3-8.
(6) The fixation agent according to one of the preceding
claims, characterised in that it contains strongly
hydrophilic compounds selected from the group
consisting of monopropylene glycol, dipropylene
glycol, polypropylene glycol, glycerol,
pentaerythritol, sorbitol, ethylene glycol, diethylene
glycol and polyethylene glycol.
(7) The fixation agent according to one of the preceding
claims, characterised in that it contains a surfactant
selected from the group consisting of ethoxylated non-
ionic surfactants with high and/or low HLB value,
polysorbates, particularly polysorbate 20, 40, 60 or
80, saponins, alkali salts of decyl sulfates, decyl
sulfonates, dodecyl sulfates, dodecyl sulfonates and
dodecylbezenesulfonates, oleates, stearates, caprates,
caprylates and betaines.
(8) The fixation agent according to one of the preceding
claims, characterised in that it is present as
anhydrous mixture of crystalline or anhydrous

- 41 -
components, which are added in the form of soluble
powder or as soluble pressed tablets to a suitable
solvent.
(9) A method for staining tissue samples fixed in a
formalin-free manner, characterised in that
in a first step the tissue sample is fixed with
the fixation agent according to one of Claims 1
to 8,
in a second step the tissue sample is prepared
for staining and is optionally cut,
- in a third step the tissue sample is stained, and
- is evaluated microscopically.
(10) Use of the fixation agent according to one of Claims 1
to 8 for preparing and fixing tissues samples for
histological or immunohistochemical stains of the
tissue sample.

Description

Note: Descriptions are shown in the official language in which they were submitted.


CA 02865584 2014-08-26
WO 2013/131816 Al
FORMALIN-FREE FIXATION AGENT FOR HISTOLOGICAL STAINS OF
TISSUE SAMPLES
(1) The invention relates to a development of a fixation
solution which effects a clear improvement of the
known histological and immunological staining
techniques as well as the staining techniques used in
pathology. In particular, the present invention
improves the quality and staining of tissue samples or
tissue sections that have not been fixed with
formalin. The present invention has proven to be
especially advantageous for sensitive tissue that is
difficult to cut when fixed with formalin, which can
not only be cut with a better quality without
artefacts, but also has a higher brilliance and colour
stability of the stain.
(2) For histological examinations in biology and medicine,
tissue samples are removed, usually fresh, from an
organism, or even entire organs or entire
animals/animal bodies/plants or organisms, are placed
in special solutions known as fixation solutions
(infiltration) or are saturated with the fixation
solution via a perfusion or instillation arrangement.
The fixation serves to fix (= preserve) the state of
the tissue at the moment of removal in order to
examine this state directly microscopically at a later
moment in time and/or to stain it and then
microscopically differentiate the stained cell or
tissue parts on the basis of their chemical properties
and therefore examine these cell or tissue parts or to
provide diagnoses.
(3) If a tissue sample is placed in the fixation solution,
reference is made to an "immersion fixation", and if
the tissue piece or organ or the entire organism is
saturated via its vascular system with the fixation

CA 02865584 2014-003-26
- 2 -
solution, reference is made to perfusion or
instillation fixation. The fixation process is a
chemical reaction of the actual fixation agent with
the proteins of the tissue. A sample is thus
preserved, that is to say decomposition processes by
enzymes, bacteria or fungi are prevented. In addition,
the tissue is hardened and is now converted into a
state in which it can be cut using a microtome into
thin slices a few um thick.
(4) Subsequently to the fixation, the tissue sample can be
embedded in paraffin, for example. To this end, the
sample is usually firstly dewatered in an alcohol
series with increasing concentrations. The alcohol is
then removed via what is known as an intermedium, the
sample is then saturated with paraffin via xylene or a
xylene replacement in a number of steps, and lastly is
cast in paraffin by means of a mould. Once the
paraffin has solidified, the paraffin block thus
obtained is processed using a microtome in order to
provide thin sections (generally between 2 and 5 um
thick).
A paraffin block can be stored in a practically
unlimited manner under room temperature conditions or
slightly cooled, that is to say for example individual
sections can be produced, and the block can then be
stored again and kept for subsequent further
processing.
(5) Instead of paraffin, other polymers can also be used
for the embedding of samples, for example celloidin,
high-molecular PEG, acrylates and others.
(6) Such thin sections are usually arranged on glass
slides and then stained in accordance with specific
instructions (what are known as histological staining

CA 02865584 2014-08-26
- 3 -
protocols or staining provisions). Only as a result of
the staining is it possible to microscopically
differentiate differences in the tissue structure,
distinguish diseased tissue from healthy tissue, and
perform diagnostic assessments, since the stains used
bind specifically to certain structures or chemical
components of the tissue structures and therefore
stain these specifically, that is to say depending on
their chemism. For example, cell nuclei can thus be
differentiated significantly from cell plasma, and
various cell types are stained differently as well as
fibres and other tissue components. The overall image
of a stain then allows a diagnostic assessment of the
examined tissue.
(7) The most conventional fixation agent in histology is
formalin. It was used for the first time as fixation
agent for tissue samples by Isaak and Ferdinand Blum
at the Senckenberg research institute in Frankfurt am
Main in the early 1890s and, from the outset, proved
to be much better suited, for example compared with
spiritus (ethanol), turpentine and other substances
(see I. Blum: 1893). Formalin very quickly became
widespread in the field of medicine and ultimately
established itself globally as the ultimate fixation
agent, because it was easy to acquire and easy to
handle, and the results are comparable with one
another over a broad field of application.
(8) Besides formalin, many further fixation agents were,
and are, also used in histology that are based on
methanol, ethanol, acetic acid, chloroform, chloral
hydrate, picric acid, mercury dichloride, potassium
dichromate, chromic acid, osmium tetroxide and various
salt solutions and salt mixtures. However, these
fixation agents are not all suitable universally, but
in each case only specifically for certain tissue

CA 02865584 2014-08-26
- 4 -
types and certain questions and further processing.
There is a direct link between fixation (fixation
agent), tissue preservation and result of the stain,
which ultimately can be evaluated by microscope. Since
the fixation in the majority of cases constitutes a
chemical reaction (in this respect see "Histological
Techniques, Laboratory Columbia Manual University",
1975), which influences the chemical properties of the
tissue, it has long been known already that certain
dyes or certain dye solutions are only compatible with
certain fixation agents or fixation methods or are
incompatible therewith. When, for example, fixation is
performed using ethanol or using ethanol/acetic acid
mixtures, tissue differentiations can in principle
only still be performed with a great deal of
difficulty, both because cells and tissue are severely
dehydrated in the case of ethanol fixation and shrink,
and also because mordant dyes for example do not
provide satisfactory results. On the other hand,
stains with use for example of picric acid have a much
more brilliant and vibrant manifestation than with use
of formalin as fixation agent, and therefore pre-
treatments of the sections with picric acid are even
recommended in some staining protocols.
(9) Although formalin was initially distinguished as an
excellent fixation agent, it was observed over time
that some problems occurred with numerous staining
techniques in histology and pathology. Since
formaldehyde oxidises in solution and in contact with
the air to form formic acid, what are known as
"formalin pigments" form in blood-rich samples. These
highly refringent crystals are formed from the
reaction of formic acid and blood and are perceived in
histology and pathology as interfering artefacts.
Stabilisers against the polymerisation, which are
added to the commercial formalin solution, such as

CA 02865584 2014-08-26
- 5 -
methanol and butanol, may also negatively influence
the results of histological staining, since they act
in a dehydrating manner (similarly to ethanol) and
interfere with some dye/tissue bonds.
(10) Formalin also plays a central role in a special branch
of histology, which is known as immunohistochemistry.
Here, however, formalin is not generally used as
"formalin 4 %", but as "paraformaldehyde solution".
Paraformaldehyde (PFA) is the polymerised form of
formalin, which is obtainable in the industry as
powder and can be dissolved completely in hot,
alkaline solution.
Formalin, (the aqueous solution of formaldehyde gas)
has the property in aqueous solution of forming chains
of paraformaldehyde, which can precipitate.
Furthermore, formaldehyde decomposes under the action
of light, heat and/or oxygen to form formic acid. In
an aqueous formalin solution, degradation and
polymerisation reactions take place constantly, as a
result of which the formaldehyde is broken down
continuously. Since there are also reformation
reactions (depolymerisation of the PFA chains, and
also balanced reactions), the percentage of
formaldehyde in an aqueous solution can never be
specified exactly.
The "stock solution", which is known under the trade
name "Formol", has a formaldehyde concentration of 35-
37 %, sometimes also 37-38 %. Formol is offered in
various qualities: technical, stabilised and buffered.
Here, additives are admixed to this saturated
formaldehyde solution: stabilised Formol is stabilised
with methanol (in order to prevent PFA formation), and
buffered Formol is buffered with calcium carbonate,
borax or a phosphate mixture (against the reduction of

CA 02865584 2014-08-26
- 6 -
the pH value in the event of decomposition to form
formic acid). A 4 % formalin solution is then produced
from this stock solution by means of dilution
(approximately 1 + 9) and is consequently not exactly
4 %, but rather 3.5-3.9 %. Some producers offer 4 %
formalin as "actual" 4 % formalin, that is to say the
stock solution is not diluted 1 + 9, but is diluted in
accordance with actual percentages by mass.
(11) Nevertheless, the result is also a solution in which
the content of formalin fluctuates and reduces
successively. For "normal" histological questions,
this is largely unproblematic, but for
immunohistochemical questions this fluctuating
composition, which may additionally have a fluctuating
pH value due to the formation of formic acid, may be
disadvantageous. Some histological stains are also
negatively influenced by an excessively low pH value
of formalin (for example the differentiation of
oxidative and glycolytic muscle fibres). A fixation
solution with exact concentrations of 4 %, 6 % or 8 %,
which is adjusted via a buffer to an exact pH value
(for example 7.0, 7.2 or 7.4, which corresponds to a
conventional pH value of animal/human tissue), is
therefore produced from paraformaldehyde for IHC
questions. However, such buffered PFA solutions only
last for a short period of time, that is to say they
have to be used up within a few days, because
otherwise exactly the same decomposition and balanced
reactions as with normal formalin solution take place.
For IHC questions, in which the degree of cross-
linking of the proteins with one another plays a key
role, buffered PFA is therefore used, because in this
case more uniform and more reproducible fixation and
reaction conditions are attained.

CA 02865584 2014-08-26
- 7 -
(12) The disadvantages and inadequacies of formalin (and
also of PFA) have long been known and lie not only in
their pungent, sharp smell, which is bothersome and
unpleasant, but also constitute a significant health
risk according to more recent findings. In the EU, a
list of the dangerous chemicals (VHCCs or very high
concern chemicals) has been compiled and updated
within the scope of the REACH Regulation (EC
Regulation 1907/2006, with amendments in EC No.
1354/2007 and 1272/2008, implemented in German law in
the Chemicals Act of 2 July 2008), and measures have
been adopted as to when and how such VHCCs are to be
avoided in future or use thereof limited or replaced.
(13) A further disadvantage of formalin-fixed tissue pieces
is the fact that such tissue pieces tend to harden
over long periods of storage, which has a negative
effect on the cuttability and stainability of the
tissue. Generally, some tissues that have been fixed
in formalin become brittle and cracked and can hardly
be cut or can only be cut with difficulty (for example
liver, kidneys, spleen, muscles, nerve tissue, brain).
(14) A further negative of formalin is the shrinkage and
the dissolving out of fats and glycogen. A shrinkage
of up to 10 % of the tissue volume is normal in the
case of formalin fixations. This leads to cracks in
the tissue and also to some sort of misinterpretation
in terms of the expansion and size of certain
structures.
(15) Considered on the whole, formalin and also buffered
PFA in an overall view of the known fixation agents
are not the fixation agents that deliver the best
results, but rather the fixation agents that deliver
comparable results due to the many years of experience
and that could be used and acquired cost-effectively.

CA 02865584 2014-08-26
- 8 -
(16) Another variant of examining tissue in a state that is
as fresh as possible is the frozen section. Here, the
state is fixed by immediate freezing following the
sample removal. Here, however, there is no cross-
linking of the proteins with one another. The sample
will only last as long as it is held at corresponding
low temperature. In addition, the freezing has to be
implemented suddenly to very low temperatures
(generally < -78 C), because otherwise the formation
of water crystals could destroy fine structures of the
tissue. The "frozen section" is what is known as the
quick section and is generally produced only for
special applications in which, for example, there is
no time to wait for the chemical fixation reaction
(for example quick diagnostics during an operation) or
when the stain or an immunohistochemical detection has
been disturbed from the outset by the fixation itself.
Under these conditions, a diagnostic decision can be
made with the disadvantages of the frozen section.
(17) However, experience generally indicates that stains on
fresh tissue are often more intensive and vibrant and
that staining times have to be reduced. Where
possible, this is due to the fact that the binding of
the dyes often is not coupled to the chemical changes
caused by the fixation, but because the dyes bind to
the tissue components themselves. The chemical
fixation reaction can thus be identified here in wide
areas as being disruptive for a stain that provides
good differentiation.
(18) Consequently, the frozen section would be the
qualitatively better approach for many stains if it
were not so difficult to handle and to store.

CA 02865584 2014-003-26
- 9 -
(19) The disadvantages in the case of frozen sections
include, for example, the technical outlay of the
conservation (immediate freezing following removal),
the problem of longer-term storage (the storage
temperature may not be exceeded), the relatively thick
sections (generally around 10 lam), the impossibility
of decalcifying a frozen section, etc. For this
reason, the fixation of a tissue sample is a necessary
step in order to ensure permanent and longer-term
conservation.
(20) For these reasons, there is a considerable need to
provide further alternatives that allow comparable or
even better stainability of tissue samples and
sections, and therefore improve the diagnostic
research.
(21) The provision according to the invention of an
alternative fixation agent for tissue samples of all
types, in particular for histology and
immunohistochemistry, is based precisely on this
overall situation and confronts the problem of
ensuring that tissue samples of all types, with use of
the fixation according to the invention, and also all
staining techniques are accessible and enable at least
comparable, if not better staining success.
(22) To this end, the invention provides a formalin-free
solution, which is suitable for fixing tissue samples
of all types and for improving the stainability of the
samples. The solution according to the invention is
characterised by the fact that, due to the acid
present in the composition according to the invention,
a total aldehyde concentration of at least 0.5 mo1/1,
but where necessary also considerably more, can be
released.

CA 02865584 2014-08-26
- 10 -
(23) To this end, the solution according to the invention
includes the components of Claim 1. Preferred
embodiments or applications are formulated in the
dependent claims.
(24) In particular, the solution according to the invention
contains
- at least one polyamine, selected from the group
consisting of urotropine triazines, mono-, di-,
tri-, tetra-, penta- or hexamethylol melamine,
dimethylol-dihydroxyethylene urea, tetramethylol
acetylene diurea, dimethylol propylene urea,
acetoguanamine or 5,5-dimethylhydantoin, and
mixtures thereof, and
- at least one acidifier selected from the group of
free bivalent or polyvalent acids consisting of
oxalic acid, fumaric acid, tartaric acid, maleic
acid, succinic acid, hydrochloric acid, acetic
acid, propionic acid, formic acid, mono-, di- or
trichloroacetic acid or chloroacetic acid, boric
acid, phosphoric acid, or mixtures thereof,
characterised in that the polyamine reacts with
the protons released by the acid, thus forming
aldehydes. Compositions that for example form
formaldehyde, glyoxal, glutaraldehyde, ethanal or
propanal and where applicable are able to release
these are particularly preferred.
(25) The molar ratio between concentration of the maximum
releasable aldehydes in mol to the concentration of
the maximum releasable protons in mol is 1:0.7 to
1:1.5, preferably 1:0.7 to 1:0.9, more preferably
1:0.8 to 1:1, more preferably 1:0.9 to 1:1.2, more
preferably 1:1 to 1:1.4 and/or more preferably 1:1.2
to 1:1.5 in the solution according to the invention

CA 02865584 2014-08-26
,
- 11 -
and is therefore selected such that a ratio of at
least 0.5 and at most 2 is set between "total
releasable aldehyde" and "total protons releasable
from the acid".
(26) The solution according to the invention is further
characterised in that the solution comprises at least
one further polyfunctional aldehyde selected from the
group consisting of citral, 3,7-dimethylocta-2,6-
dienal, geranial, (E)-3,7-dimethlyocta-2,6-dienal,
propanal, butanal, valeric aldehyde, pentanal,
hexanal, heptanal, octanal, nonanal, decanal (2 E)-3-
phenylprop-2-enal, benzaldehyde,
phenylmethanal,
vanillin aldehyde, 4-hydroxy-3-methoxyphenylmethanal,
and mixtures thereof.
(27) These compounds are preferably aldehydes that still
have one or more additional chemical functional
groups. These chemical functional groups can be
selected from the following: aryl groups, whether
phenyl, naphthyl, thienyl, indolyl, etc., linear or
branched alkyl, alkenyl or alkyne groups, and also
corresponding halogenated groups; groups with oxygen
hydroxyl, carbonyl, aldehyde, halogen formyl,
carbonate ester, carboxylate, carboxyl, ester,
hydroxyperoxy, hydroxy, ether; groups with nitrogen,
such as carboxamide, amines, imines, imides, azides,
azo, cyanates, nitrates, nitrile, nitrosooxy, nitroso
and pyridyl; groups with sulfur such as sulfhydryl,
sulfides, disulfides, sulfinyl, sulfonyl, sulfino,
sulfates, thiocyanates, carbonothioyl; groups with
phosphorous, such as phosphino, phosphono, phosphate.
(28) These groups can occur individually or in multiple, or
may also be present in combinations with one another.

CA 02865584 2014-003-26
,
- 12 -
(29) Here, the aldehydes for example are present with one
or more functions selected from the above-mentioned
groups, or what are known as multi-functional
aldehydes, because they can bind by means of their
aldehyde function to various points of the sample via
different chemical mechanisms and provide via their
other chemical functions, incorporated and included
inherently, docking points for the utilised dyes,
which are used in order to stain the sample. Due to
the addition of polyfunctional aldehydes, additional
chemical functional groups will therefore bind to the
tissue sample during the step of tissue fixation.
(30) The chemical functions of the multi-functional
aldehydes are selected such that certain types of dyes
are bound better than others or are also selected in
such a way that certain types of dyes are prevented or
discouraged from binding to the sample. Due to the
different affinity of the sample, which is also
referred to as differentiated chemism of the different
tissues, a spatial differentiation of the stainability
of the sample is thus attained. The control mechanism
thus attained is an advantage of the invention, by
means of which the colour contrast of the sample by
the addition of multi-functional aldehydes is
additionally controlled, because additional docking
points and reaction points are provided for the
molecules of the dyes due to the binding of these
functional groups to the tissue sample, such that an
optimal staining can not only be achieved more
quickly, but in particular a higher colour intensity,
brilliance and/or contrast can also be attained.
(31) In accordance with a further embodiment, a further
fixation solution in the context of this invention
contains hexamethylol melamine, boric acid, sodium
hydroxide, phenylmethanal, Tween 20, wherein

CA 02865584 2014-08-26
,
,
- 13 -
hexamethylol melamine is a formaldehyde cleaver, and
phenylmethanal serves as polyfunctional aldehyde. The
practical implementation for producing this
composition will be discussed in the examples.
(32) The molar concentration of the total available
aldehyde in the solution according to the invention,
which is formed from the polyamine together with the
acid, or which is produced by the polyfunctional
aldehyde, is preferably set to at least 0.5 mo1/1,
preferably 0.6-0.69 mo1/1, more preferably 0.7-0.79
mo1/1, more preferably 0.8-0.89 mo1/1, more preferably
0.9-0.99 mo1/1, more preferably 0.99-1.2 mo1/1, in the
solution according to the invention. With such a
solution, an optimal fixation of tissue samples is
ensured, which improves both the cuttability of the
sample and also has a positive influence on the
stainability of the sample.
(33) In order to prevent the sample from drying out, a
highly hygroscopic chemical can be added to the sample
as further additive, which is selected from the group
containing monopropylene glycol, dipropylene glycol,
polypropylene glycol, glycerol, pentaerythritol,
sorbitol, ethylene glycol, diethylene glycol and
polyethylene glycol.
(34) In order to reduce the surface tension of the solution
and to improve the creep properties, a surfactant can
be added to the solution as further additive, which is
selected from the group containing ethoxylated non-
ionic surfactants with high and/or low HLB value,
polysorbates, particularly polysorbate 20, 40, 60 or
80, saponins, alkali salts of decyl sulfates, decyl
sulfonates, dodecyl sulfates, dodecyl sulfonates,
dodecylbezenesulfonates, oleates, stearates, caprates,
caprylates and betaines.

CA 02865584 2014-08-26
- 14 -
(35) In order to adapt the isotony and osmolarity of the
solution, organic or inorganic salts can also be used,
which are selected from the group of lithium
chlorides, sodium chlorides, potassium chlorides,
calcium chlorides, strontium chlorides, lithium
sulfates, sodium sulfates, potassium sulfates, calcium
sulfates, strontium sulfates, lithium acetates, sodium
acetates, potassium acetates, calcium acetates,
strontium acetates, lithium citrates, sodium citrates,
potassium citrates, calcium citrates, strontium
citrates, lithium nitrates, sodium nitrates, potassium
nitrates, calcium nitrates, strontium nitrates,
lithium succinates, sodium succinates, potassium
succinates, calcium succinates, strontium succinates
and/or lithium formates, sodium formates, potassium
formates, calcium formates, strontium formates.
(36) In order to adapt the flow properties of the solution,
organic or inorganic thickening agents can also be
used, which are selected from the group of carbomers,
starch and modified starch, agarose, dextrose, methyl
cellulose, ethyl cellulose or propyl cellulose,
acrylic acid and PVA.
(37) In accordance with a further embodiment, the declared
solution is present in aqueous form. Furthermore, in
accordance with a further embodiment, the components
of the declared solution are provided as an anhydrous
mixture of crystalline and/or anhydrous components,
which are provided in the form of soluble powder or as
soluble, pressed tablets. This powder or these tablets
is/are dissolved by the addition of water or another
suitable solvent or mixture thereof in order to
provide a fixation solution that is ready for use.

CA 02865584 2014-003-26
,
- 15 -
(38) An advantage of the solution according to the
invention is also the pH stability thereof. The
solution according to the invention is stable in pH
ranges of pH 3-8, preferably pH 3-6. This stability is
achieved by the adjustment of the molar ratio of the
amine group to the acid groups in a ratio of
approximately 1:1. Provided free polyamine is present
in the solution, this functions as deposit, and the pH
cannot rise. This pH stability is based on the strong
buffer capacity of the polyamines, which generally
react in a slightly alkaline manner. Due to the
reaction of the polyamine, for example urotropine,
with the proton of the acid (for example citric acid),
an aldehyde and the corresponding ammonium salt are
formed. Here, an equilibrium is provided that is
influenced by the dissociation constant of the acid
and the hydrolysis constant of the polyamine and here
adjusts the pH to a certain level-at approximately pH
4 to pH 8. In the case of urotropine, 1 mol of
urotropine can consume 6 mol of protons, whereby even
small quantities of urotropine or polyamines buffer
large quantities of acid, and therefore the pH of the
solution is held at a constant value.
(39) Due to this stability, pH fluctuations can be
practically excluded. For example a pH change by
formation of formic acid is thus also avoided, and
therefore it is also impossible to find any "formalin
pigments" with use of the solution according to the
invention. Additives known to a person skilled in the
art for stabilising solutions, which additives could
interfere with a stain, such as methanol and butanol,
therefore fortunately also are unnecessary.
(40) A further advantage of the solution according to the
invention is the colour brilliance and colour
intensity of the samples fixed using the solution

CA 02865584 2014-003-26
,
- 16 -
according to the invention. Thus, practical examples
4-5 for the fixations performed by way of example
demonstrate a significant improvement of the
morphological preservation and cuttability of the
fixed samples. Furthermore, in the case of the
performed stains, specifically haematoxylin & eosin,
Masson-Goldner Trichrome, MSB-Lendrum and Azan
according to Geidies, described in examples 4 and 5,
it is shown that a significant improvement of the
stainability in general and in particular of the
colour saturation and of the colour brilliance is
attained by use of the solution according to the
invention for fixation. In addition, numerous tissues
that are difficult to process, such as brain, skin and
testes, can be much better cut and stained with the
new fixation.
(41) It is assumed, without introducing a limitation as a
result of this assumption, that the improvement of the
stainability, even with a small addition of the multi-
functional aldehydes, such as citral, 3,7-
dimethylocta-2,6-dienal, geranial, (E)-3,7-

dimethylocta-2,6-dienal, propanal, butanal, valeric
aldehyde, pentanal, hexanal, heptanal, (2 E)-3-
phenylprop-2-enal, benzaldehyde,
phenylmethanal,
vanillin aldehyde, 4-hydroxy-3-methoxyphenylmethanal,
heptanal, octanal, nonanal, decanal, and mixtures
thereof can be attributed to the fact that they are
added together in the balanced reaction.
(42) In the declared solution, such a balanced reaction
takes place, in which the polyamine with the protons
released by the acid transitions for example into an
aldehyde. The added, additional multi-functional
aldehydes are summed on the aldehyde side and can then
also be incorporated in the sample. The multi-
functional groups of these aldehydes serve here as

CA 02865584 2014-08-26
- 17 -
additional docking points for dyes, which can be bound
to these points via polar bonds, hydrogen bridges or
even covalent bonding, and thus improve the colour
reactions of the histological and/or
immunohistochemical stains used.
(43) It has fortunately been found that further problems,
which are known with other formalin-free fixations,
are also evaded or avoided by the use of the declared
solution.
Examples include the HOPE fixation (Hepes-Glutamic
acid buffer mediated Organic solvent Protection
Effect), which is particularly suitable for molecular
biological questions, since nucleic acids and antigen
structures are preserved particularly well by means of
this fixation agent. However, this fixation can be
performed only using complex apparatus and by means of
a complex processing procedure, and therefore is only
suitable with difficulty for daily routine.
Another formalin-free fixation agent is offered by the
company Anatech as "prefer fixative". This contains
glyoxal, ethanol and buffer; here, however, only few
experience values have so far been presented with
regard to the histological application. The presence
of alcohol in the solution already rules it out,
however, for numerous stains.
A further product originates from the company Sigma
and is distributed under the name Accustain. Here too,
ethanol is the main component of the fixation agent.
(44) Currently, a comprehensive testing and economical
evaluation of the results of histological stains is
not available for any of the alternative fixation
agents. The demands on a formalin-free fixation agent

CA 02865584 2014-08-26
,
- 18 -
are primarily a comparability of the result with
previous results of formalin-fixed samples, and
identical or improved handling as a matter of routine,
identical or similar fixation periods, and identical
or improved staining properties.
(45) The solution according to the invention meets these
demands and for the first time allows the fixation and
staining of tissue samples fixed in a formalin-free
manner whilst maintaining and even considerably
improving the colour saturation, colour brilliance and
colour intensity in the methods listed hereinafter:
a) Haematoxylin & Eosin staining, with use of
various haematoxylin solutions (according to
Mayer, Gill, Harris, Weigert, Verhoff, Hansen,
etc.) and Eosin solutions (in aqueous, alcohol or
methanol form with various concentrations and
additives of acetic acid or other pH-lowering
additives).
b) Trichrome staining, for example according to
Masson, Masson-Goldner, Azan, Crossmon, Mallory,
Cason, and other staining protocols which attain
a single-, two-, three- or multi-stage stain via
nuclear stains, plasma stains and fibre stains.
c) Tr-, tetra-, penta- and poly-chromatic overview
and special stains, such as Movat pentachrome,
Mollier quadruple staining, van Gieson, Hansen,
Weigert and other stains for the physiological or
chemical staining of special tissue structures.
d) Special stains or special detections of fibres,
tissue components, cell nuclei, plasma components
and chemical properties, such as elastica stains,
aldehyde detections, iron detections, other metal

CA 02865584 2014-08-26
- 19 -
detections, amyloid detections, fat staining,
representation of mucopolysaccharides, silver
stains and gold toning, selective nucleus stains,
cytological and haematological stains, calcium
detections, bone and cartilage stains, nerve
stains, etc.
(46) For all mentioned staining methods, it should be
ensured that, subsequent to the fixation, the tissue
pieces placed in the fixation agent or tissue pieces,
organs or entire organisms saturated with the fixation
agent are subjected to a conventional further
processing that is routine in the laboratory, that is
to say they are dewatered and then infiltrated with
paraffin or other embedding media (celloidin,
acrylates) and processed to form sample blocks, which
can ultimately be cut using a microtome.
(47) Here, the invention improves the plastic properties of
the fixed material, such that, when processing thin
sections, cutting artefacts are absent or only occur
to a small extent, because on the one hand there is no
tissue hardening caused by "overfixing" and on the
other hand the tissues do not shrink to such an extent
as is usual in the case of formalin fixations.
(48) Here, it has been found that the tissue pieces treated
by means of the invention can be processed
comparatively to, and sometimes even more easily than
formalin-fixed tissue samples. A further advantage of
the solution according to the invention is therefore
the fact that tissue samples that have been fixed
using this solution demonstrate excellent cutting
properties, and, with such tissues that are difficult
to cut when they have been fixed using solutions
containing formaldehyde (for example brain tissue),

CA 02865584 2014-003-26
- 20 -
there are considerable improvements to the cutting
properties.
(49) Fewer artefacts are therefore introduced into the
histological section, which enables a significant
improvement of the microscopic examination of the
sample and therefore considerably facilitates the
diagnosis of histological anomalies and abnormalities.
(50) As a result, the stains can be differentiated not only
identically, but much more firmly and much better
compared with stains on formalin-fixed samples, since
colour differences in the histological section are
sharper and more vibrant than is the case with
formalin-fixed samples, and the colours themselves are
brighter and more selective for differences in the
chemism of the tissue.
(51) The tissue preservation is additionally advantageous.
Shrinkage hardly occurs, and when it does it is to a
much smaller extent than with formalin fixations. Cell
nuclei retain their round shape and can be stained
very well using conventional nucleus dyes. Even in the
finest of structures, an excellent preservation can be
observed, which even equals the preservation of
fixations using fixation agents containing sublimate
and picric acid.
(52) The simple handing is also advantageous. The
established laboratory routines do not have to be
changed, since fixing times and application can remain
identical. Tissue samples are introduced into the
sample containers with the invention and remain there
until further processed. The fixing times correspond
to those of formalin. Longer fixations are not
problematic and may even be advantageous. However, an
unwanted overfixing of the tissue during treatment

CA 02865584 2014-08-26
,
- 21 -
with the solution according to the invention should
not be observed in any case. Further, the declared
solution is harmless in terms of hazardous materials
and dangerous substances and can also be handled as
harmless chemical waste with regard to disposal.
(53) The invention furthermore also relates to the use of
the solution as a preservative for macroscopic
preparations, that is to say including entire animal
bodies or corpses, as are used in the field of
anatomical science. In addition, it can also be used
for the fixing and long-term preservation of
biological sample material in natural history museums,
zoological Or botanical collections, research
collections and teaching collections.
(54) The invention also relates to the use of the fixation
agent for immunohistochemical stains with paraffin-
conventional antibodies and also for antibodies that
are suitable for frozen sections or for plastic
preparations.
Description of the figures:
Figure 1: shows a comparison of staining results of an
AZAN stain on a tissue sample, specifically rat
cerebellum, wherein the sample used for Figure lA was
fixed using formalin 4 % in accordance with standard
methods and the sample used for Figure 1B was fixed in
an identical method, but using the solution according
to the invention. It can be clearly seen that Figure
1B has fewer cracks, demonstrates an improved
preservation of the preparation and of the neurons,
and also adopts a more vibrant staining.
Figure 2: shows a comparison of staining results of a
HAEMOTOXYLIN & EOSIN (H&E) stain on a tissue sample,

CA 02865584 2014-08-26
- 22 -
specifically rat testes, wherein the sample used for
Figure 2A was fixed using formalin 4 % in accordance
with standard methods and the sample used for Figure
2B was fixed in an identical method, but using the
solution according to the invention. It can be clearly
seen that Figure 2B has clear delimited structures,
fine structures are better preserved, and the sample
adopts a more vibrant staining.
Figure 3: shows a comparison of staining results of an
MSB LENDRUM stain on a tissue sample, specifically rat
testes, wherein the sample used for Figure 3A was
fixed using formalin 4 % in accordance with standard
methods and the sample used for Figure 3B was fixed in
an identical method, but using the solution according
to the invention. It can be clearly seen that in
Figure 3B the differentiation of the fine structures
is better, and the sample adopts a more vibrant
staining.
Figure 4: shows a comparison of staining results of a
MOVAT stain on a tissue sample, specifically rat lung,
wherein the sample used for Figure 4A was fixed using
4% formalin in accordance with standard methods and
the sample used for Figure 4B was fixed in an
identical method, but using the solution according to
the invention. It can be clearly seen that Figure 42
has clearer delimited structures, fine structures
(bronchi and alveoli) are better preserved, and the
sample adopts a more vibrant staining.
Figure 5: shows a comparison of staining results of a
MASSON TRICHROME stain on a tissue sample,
specifically rat tongue, wherein the sample used for
Figure 5A was fixed using formalin 4 % in accordance
with standard methods and the sample used for Figure
5B was fixed in an identical method, but using the

CA 02865584 2014-08-26
- 23 -
solution according to the invention. It can be clearly
seen that Figure 5B has a sharper differentiation of
the fine structures, the stain leads to cell nuclei
stained more vibrantly, and the sample as a whole
adopts a more vibrant staining.
Examples
Example 1: Composition and component of a fixation agent
POS. PRODUCT G/L Use Range
1 Urotropine 4 40 up to 20 %
2 Citric acid 5.43 54.29 up to 35 %
1.43 x
3 TWEEN 80 0.143 up to 5 %
10E-2
4 Monopropylene glycol 2.86 28.57 up to 20 %
(2 E)-3-phenylprop-2- 4.29 x
0.429 up to 5 %
enal 10E-2
0.71 x
6 SPAN 80 0.07 up to 5 %
10E-2
H20 or suitable filling to
7 87.65 876.5
solvent. 100 %
8 TOTAL 1000
Example 1.1: Calculation of the molar ratios of the
fixation agent to tissue fixation
With a composition according to Example 1 with the
components urotropine and citric acid, the molar ratio
is calculated as follows:
Urotropine releases up to 6 mol formaldehyde from 1
mol urotropine. Citric acid releases up to 3 mol
protons from 1 mol citric acid. 1 mol citric acid
(anhydrous) = 192.124 g/mol => 192.124 g; furthermore,
1 mol urotropine = 140.19 g/mol => 140.19 g.
A solution that contains 4 % urotropine and 5.5 %
citric acid (as proposed in Example 1) thus achieves a

CA 02865584 2014-08-26
,
- 24 -
molar concentration of urotropine of 0.28 M and can
form at most up to 1.71 M formaldehyde. Further, the
molar concentration of citric acid is 0.28 M and can
form at most up to 0.85 M protons.
This means that, in the solution from Example 1, 0.85
mol formaldehyde can be formed from HMTA and an excess
of HMTA also remains in the solution. The molar ratio
between total releasable aldehyde and total protons
releasable from the acid is in this case approximately
2:1, wherein it must be taken into consideration that
urotropine is present in excess.
In the case of a balanced reaction, in which 0.85 mol
formaldehyde can be formed, the solution functions
excellently as a fixation solution for histology (see
Example 5 and Figures 1 to 5).
1.2. Comparative calculation: on the example of another
conventional solution:
A known solution containing 1 % hexamethylenetetramine
(HMTA) and 1 % citric acid, in accordance with the
corresponding calculation as under Example 1.1., has a
molar concentration of HMTA of 0.07 M and can form at most
up to 0.42 M formaldehyde. Here, the molar concentration of
citric acid is 0.052 M and can form at most up to 0.156 M
protons.
This means that, with this known solution, at most 0.156
mol formaldehyde can be formed from HMTA and an excess of
HMTA remains in the solution. The molar ratio between total
releasable aldehyde and total protons releasable from the
acid is in this case approximately 2.6:1.
If a maximum of 0.156 mol formaldehyde is formed, the
solution does NOT function as a fixation solution for

CA 02865584 2014-08-26
- 25 -
histology, since all known side-effects occur, as also
described in the text above, such as shrinkage and
morphological changes up to the onset of degeneration of
the tissue. The aforementioned values were confirmed by way
of experiment for HMTA and citric acid.
Example 2: Composition and components of a further
ref erred embodiment
PRODUCT G/L Use Range
Hexamethylol
6 60 0-20 %
melamine
Boric acid 3 30 0-35 %
Sodium hydroxide 0.4 4 0-5 %
Dipropylene glycol 2.86 28.57 0-20 %
Phenylmethanal 0.01 0.1 0-5 %
Polysorbate 20 0.01 0.1 0-5 %
H20 or suitable
87.65 876.5 10-99 %
solvent
TOTAL 1000
Hexamethylol melamine, referred to hereinafter as HMM,
enters into the following balanced reaction:
HO-C. C1O1
9 0 a
1.13112
Aµl t4r"fi ti"'H HAH H fi"
Lime- Tetra- armee. Poem.
HOH2C, CH2OH
kH2 .t:4 N'
6112orf 642OH
1 2
Melamine HMM
This reaction best takes place at pH 6-8, which is why
a weak acid, specifically boric acid, is used in
accordance with the present embodiment. The pH is
adapted with sodium hydroxide. It may be that -> 6 mol
formaldehyde are released per mol HMM. This gives:
1 mol HMM 270g
1 mol formaldehyde 30g
1 mol HMM contains 6 mol aldehyde or 180g

CA 02865584 2014-08-26
- 26 -
In order to obtain a solution with total releasable
formaldehyde content of 4 96/1, 40 g releasable
formaldehyde or 60 g HMM are consequently required.
Three protons are cleaved from the boric acid. Boric
acid can be represented by the formula H3B03 and has a
molar mass of 61.83 g. In order to obtain 6 mol of
protons, 27.5 g are therefore required, that is to say
30 g of boric acid calculated with slight excess,
based on 1000 ml solution.
In the present composition, a ratio of total
releasable aldehyde/total releasable protons of
approximately 1:1 is produced.
Example 3: Further alternative embodiments
In accordance with the calculations presented above in
Example 1.1 and also Example 2, further alternative
compositions can be prepared. The components that can
be used alternatively are specified in the table
below.
Any combination of the substances specified under
Position 1 with the substances from Position 2 is
possible. Where appropriate, the substances from
Position 5 are combined, for example in order to thus
adjust the proportion of total releasable aldehyde. In
accordance with the invention, a solution formed by
these combinations must comprise at least 0.5 mo1/1 of
total releasable aldehyde. The substance alternatives
of Positions 3 and 4 and also 6 and 7 are optional and
can be combined as necessary.

CA 02865584 2014-08-26
- 27 -
POSITION ALTERNATIVE COMPONENTS
based on the
table in
Example 1
urotropine, triazines, dimethylol,
dihydroxyethylene urea, tetramethylol
acetylene diurea, mono-, di-, tri-,
1 tetra-, penta- or hexamethylol
melamine, dimethyl propylene urea,
acetoguanamine or 5,5-
dimethylhydantoin, or mixtures thereof
oxalic acid, tartaric acid, succinic
acid, hydrochloric acid, acetic acid,
propionic acid, formic acid, mono-, di-
2 or tri chloroacetic acid or
chloroacetic acid, uric acid, citric
acid, boric acid, phosphoric acid, or
mixtures thereof
TWEEN 80, polysorbate 20, 40, 60 or 80,
alkalines, lauryl sulfates;
dodecyl sulfates, dodecyl sulfonates,
dodecylbenzene sulfonates; ethoxylated
fatty acids; ionic and non-ionic
surfactants with high HLB (hydrophilic-
lipophilic balance) value, (in
3
chemistry describes the hydrophilic and
lipophilic proportion of primarily non-
ionic surfactants and was proposed in
1954 by W. C. Griffin. Surfactants with
a high HLB value cause a good wetting
of hydrophilic surfaces), or mixtures
thereof
mono-, di- or further polypropylene
glycols; glycerol, mono-, di-, or
4 further polyethylene glycols; sorbitol,
pentaerythritol, low-molecular PEG,
high-molecular PEG, and mixtures

CA 02865584 2014-08-26
,
- 28 -
thereof
citral, 3,7-dimethylocta-2,6-dienal,
geranial, (E)-3,7-dimethylocta-2,6-
dienal, propanal, butanal, valeric
aldehyde, pentanal, hexanal, heptanal,
octanal, nonanal, decanal, (2 E)-3-
phenylprop-2-enal, benzaldehyde,
phenylmethanal, vanillin aldehyde, 4-
hydroxy-3-methoxyphenylmethanal, and
mixtures thereof
SPAWN 80, polysorbates, lauryl
6 sulphates, ethoxylated fatty acids,
ionic and non-ionic surfactants with
low HLB, or mixtures thereof
7 H20; alcohols; acetones; dimethyl
sulfoxide; alkyl carbonates; polar
organic solvents, and mixtures thereof
Example 4: Method for the preparation of histological
samples for microscopic examination.
In accordance with the inventive method, the tissue
sample should be introduced as fresh as possible into
the fixation solution, for example the solution
according to Example 1. Generally, it is usual for the
quantity of fixation solution to correspond to twenty
times the sample volume and for the fixation period to
be dependent on the sample size. Depending on size,
the samples remain in the fixation solution from 12 to
36 hours, and larger samples may also remain in the
fixation solution for 72 hours or longer. A diffusion
distance or penetration rate of 1 mm in 2-4 hours is
assumed.
In order to then embed the sample in paraffin or other
embedding agents, a complete dewatering of the sample
is necessary. The sample is first removed from the

CA 02865584 2014-08-26
- 29 -
fixation solution, washed in flowing water and
immersed in a series of alcohols in rising
concentration. The steps between the concentration
stages are here 30-50-60-70-80-90-96-100, for example.
Ethanol or isopropanol are usually used as alcohols.
Following the dewatering, the sample is immersed in a
suitable organic solvent, which is miscible both with
alcohol and with the embedding medium, then the
infiltration with the actual embedding medium
(paraffin) follows in a number of stages, in each case
for a number of hours (depending on the sample size).
The sample is cast into a suitable mould with a small
quantity of paraffin. Once the block has solidified,
the block is removed from the mould and then can be
cut. Using a suitable microtome, sections 4-6 pm thick
are produced and are arranged on glass slides.
The glass slides with the paraffin sections can be
stored for a relatively long period of time. However,
further processing, that is to say staining, generally
occurs directly. Here, the paraffin first has to
removed again and the tissue section itself watered.
The procedure previously described is performed in the
reverse order, that is to say the paraffin is
dissolved out using xylene, followed by alcohol 96 %,
90 %, 80 %, 70 % or a similar sequence up to water.
The staining then starts, wherein, in the case of dyes
that are present in alcohol solution, the steps up to
complete watering can be omitted and the glass slides
can be immersed directly into the alcohol staining
solution.
Example 5: Assessment of the morphological preservation,
cuttability and stainability of paraffin preparations
With the aid of conventional histological stains, it
was possible to carry out a diagnostic evaluation of

CA 02865584 2014-08-26
- 30 -
section samples. The sections were produced from
tissues which had previously been fixed either in the
solution from Example 1 or in 4 % formalin. The
qualitative evaluation was performed on four stains
selected by way of example: (1) haematoxylin & eosin
(HE), (2) Azan according to Geidies, (3) Masson
Goldner Trichrome and (4) MSB Lendrum. The
histological diagnostic evaluation detects the
parameters morphological preservation and stainability
of the sections. The parameter cuttability was
assessed during the cutting process performed on
various tissues.
Stains used by way of example
HAEMOTOXYLIN & EOSIN: the conventional H & E stain
uses the dyes haematoxylin in the composition
according to Mayer and eosin. Both dyes are offered in
aqueous solution (eosin possibly also as alcohol
solution) with a defined pH value and/or a defined
acid addition and provide a characteristic colour
image. Cell nuclei are generally stained blue-purple
here. In this case, the dye haematoxylin, which is
offered as Alaun complex, reacts with the chromatin of
the cell nuclei. In order to obtain a stable water-
and alcohol-insoluble coating, this compound is then
immersed in tap water or in a salt solution mixed with
monovalent metal ions. The eosin solution is set in
aqueous form to a pH value of approximately 4.0, which
leads to a characteristically illuminating orange
colour image. Eosin binds in different intensity to
various tissue and cell structures and thus allows a
good differentiation of the histological section.
MASSON GOLDNER TRICHROME: the Masson Goldner Trichrome
and the Crossman stain are also conventional
histological stains which function as Trichrome

CA 02865584 2014-08-26
- 31 -
staining with three (or four) dyes. Here too, the
nuclei are stained with haematoxylin, but not with an
Alaun complex, but via an iron complex. This does not
lead to a cell nucleus stained blue-purple, but to a
brown-black cell nucleus, which can be differentiated
very clearly, even with respect to tissue components
stained blue. A mixture of acid fuchsin, ponceau and
azophloxine is used as a second dye and binds
differently to different tissue regions and makes it
possible to identify cell plasma and other
intracellular structures. This dye complex reacts
directly with the respective tissue structures. A
further dye, Orange G, is what is known as a mordant
dye, which forms a water- and alcohol-insoluble
coating with certain tissue structures only in the
presence of a bivalent metal ion, for example as is
provided by phosphotungstic acid or phosphomolybdic
acid. In particular, erythrocytes and muscles can be
presented using this dye and can be significantly
distinguished from other tissues. Keratinous material
is also stained considerably with Orange G.
Alternatively, aniline blue or light green is used as
a fourth dye. These are conventional fibre dyes, which
bind particularly with collagens and intercellular
structures. Cartilage and bone material also bind to
these dyes, depending on chemism. Different blue or
green intensities ultimately allow diagnostic
conclusions concerning the fibre composition, wherein
aniline blue generally provides the differentiated
image.
MSB LENDRUM: the MSB Lendrum stain is a stain related
to the Masson Goldner Trichrome, in which, however,
the dyes Martius yellow and crystal ponceau are
offered instead of acid fuchsin/azophloxine/ponceau
and instead of Orange G. This results in an image that
is comparable, but differentiated further still,

CA 02865584 2014-08-26
- 32 -
wherein the significance of the MSB staining is of
particular value, especially for vascular structures,
because muscles, fibre arrangement and vessel inner
walls are better differentiated here than with the
previously mentioned Trichrome stains.
AZAN ACCORDING TO GEIDIES: the AZAN stain also belongs
to the series of conventional Trichrome staining. The
original variant according to Heidenhain works in the
pre-treatment of the sections with aniline alcohol,
azocarmine for nucleus staining, phosphotungstic acid
for staining and a dye mixture of aniline blue and
Orange G and lasts for a number of hours. By contrast,
the variant modified according to Geidies dispenses
with aniline alcohol, and instead uses the azocarmine
nuclear fast red and drastically reduces the staining
times. The result of the stain is so similar that the
conventional AZAN stain can be largely replaced. The
results are substantially comparable to those of the
Masson Goldner and MSB Lendrum. Cell nuclei are
stained deeply red by the nuclear fast red provided in
aluminium sulfate solution and contrast well with the
continuous blue background. Aniline blue and Orange G
produce the counter or background stain (blue) and a
well differentiated staining of the erythrocytes
(orange) and of the muscle plasma (also deeply
orange). In addition, creatine and callous epithelia
are also stained significantly orange. The basic
substance and fibres obtain different blue shades as a
result of the aniline blue. The result of the aniline
blue stain is influenced on the whole very strongly by
the stain duration.
5.1 Morphological preservation
In order to assess the morphological preservation at
light microscopy level, the following parameters can

CA 02865584 2014-003-26
,
- 33 -
be used: (A) fragmentation of the tissue (crack
formations) and (B) the presentation of the cell
nuclei (nuclei) and (C) of the cell bodies (stomata).
The fragmentation of the tissue by the formation of
individual cracks or propagated crack networks results
from deficient fixing and manifests itself as the
tissue section is drawn on the hot water bath or the
hot plate and also during the staining process. During
the course of the heat-induced drawing of the paraffin
and therefore also of the tissue section penetrated
and covered by paraffin, a physical loading of the
paraffin/tissue association is produced, which may
result, in the case of deficient fixing, in the
breaking of the tissue. The tensile and/or shear
forces occurring during deparaffinisation and staining
of the tissue section are applied particularly to
these tissue points, which are already strained during
the drawing process, expand these tissue points or
break the tissue entirely. The tendency for crack
formation is proportional to the adhesive property of
the slide used.
The score is awarded between (no fragmentation of the
tissue, 1) and (cell nuclei and cell bodies in their
natural form, 1) and (tissues destroyed by crack
formation and detached, 4) and (cell nuclei angular
and severely shrunken, cell body massively shrunken
with strong "ring formation", 4).
General criteria
Fragmentation Score Cell Score Cell body Score
nuclei
No 1 Natural 1 Natural 1
fragmentation
Slight 2 Slightly 2 Minimal 2

CA 02865584 2014-08-26
- 34 -
fragmentation angular shrinkage
Moderate 3 Moderately 3 Moderate 3
fragmentation angular shrinkage
Extreme 4 Cell 4 Massive 4
fragmentation: nucleus shrinkage
tissue is angular and/or
destroyed over and ring
a large area severely formation
shrunken
5.2 Cuttability
A further criterion in the histological processing of
tissue samples is what is known as the cuttability of
the tissue. The different properties of fixation
agents result, usually in accordance with the
incubation time, in a different cuttability or load-
bearing capacity of the tissue. A tissue, for example,
can be brittle and fragile (no cuttability, 4) or
supple and resistant (high cuttability, 1) as a result
of the fixation. Different tissue properties of
different tissue types have to be taken into
consideration in the assessment.
General criteria
Cuttability Score
High cuttability 1
Above-average cuttability 2
Below-average cuttability 3
No cuttability 4
5.3 Stainability
Histological stains of tissue sections often allow
various distinctions between individual cells, but
also tissue types, depending on the dye combinations
used. This histological differential diagnosis applied

CA 02865584 2014-08-26
- 35 -
in human and veterinary diagnostics, but also in
medical, zoological and botanical research, is based
on the differentiation of nucleus types, but in
particular also on the differentiation of dye
precipitation on cells and/or tissues. A maximum dye
saturation, uniform colour precipitation, good
contrasting (between cell nucleus and cell body) and
also a high colour brilliance are therefore not only
desirable, but also absolutely necessary requirements
of a stain.
Chemical reactions between the fixation agent and the
tissue influence not only the cuttability and the
load-bearing capacity of the tissue, but also the
stainability thereof. Different fixation agents can
improve, but also reduce the stainability of a tissue
section depending on the incubation time. In order to
determine the stainability of tissues, the following
criteria are used: 1. colour saturation, 2. uniform
colour precipitation, 3. contrast between cell nucleus
and cell body and 4. colour brilliance. The individual
stains have to be assessed separately from one
another, since stains or components thereof respond
differently to the influence of fixation agents.
General criteria
1. Colour saturation Score
Very good colour saturation 1
Good colour saturation 2
Moderate colour saturation 3
Inadequate colour saturation 4
2. Colour precipitation Score
Uniform colour precipitation without 1
oversaturation
Colour precipitation with low 2
fluctuations

CA 02865584 2014-08-26
- 36 -
Partly irregular colour precipitation 3
Completely irregular colour 4
precipitation
3. Contrast (cell nucleus/cell Score
body)
Very good contrast (generally good 1
differentiability of nucleus
components and/or nucleus membranes)
Good contrast (largely good 2
differentiability of nucleus
components and/or nucleus membranes)
Moderate contrast (little 3
differentiability of nucleus
components and/or nucleus membranes)
Poor contrast (no differentiability 4
of nucleus components and/or nucleus
membranes)
4. Colour brilliance Score
Very high colour brilliance 1
High colour brilliance 2
Low colour brilliance 3
Very low colour brilliance 4
5.4 Evaluation/result
The described criteria catalogue forms the basis for
the presentation below of the results in table form.
Section samples were produced following a 24/hr
fixation period in the solution according to Example 1
or 4 % formalin from the following tissues: brain,
heart, lung, kidney, skin and testes. These were then
stained simultaneously with HE, Azan according to
Geidies, Masson Goldner Trichrome and MSB Lendrum.

CA 02865584 2014-08-26
,
,
- 37 -
1. Morphological preservation:
Criterion Solution according Formalin
to Example 1
Fragmentation 1 3
Cell nuclei 2 2
Cell bodies 2 2
2. Cuttability
Tissue type Solution according Formalin
to Example 1
Brain 1 2
Heart 2 2
Lung 2 3
Kidney 2 3
Skin 1 2
Testes 1 2
3.a. Stainability (H & E):
Criterion Solution according Formalin
to Example 1
1. Colour 1 2
saturation
2. Colour 2 3
precipitation
3. Contrast 1 2
4. Colour 1 2
brilliance
3.b. Stainability (Azan according to Geidies)
Criteria Solution according Formalin
to Example 1
1. Colour 1 2
saturation
2. Colour 2 2
precipitation
3. Contrast 2 2

CA 02865584 2014-08-26
- 38 -
4. Colour 1 3
brilliance
3.c. Stainability (Masson Goldner Trichrome):
Criteria Solution according Formalin
to Example 1
1. Colour 1 2
saturation
2. Colour 2 3
precipitation
3. Contrast 1 2
4. Colour 1 3
brilliance
3.d. Stainability (MSB Lendrum):
Criteria Solution according Formalin
to Example 1
1. Colour 1 3
saturation
2. Colour 2 3
precipitation
3. Contrast 2 4
4. Colour 2 4
brilliance

Representative Drawing
A single figure which represents the drawing illustrating the invention.
Administrative Status

For a clearer understanding of the status of the application/patent presented on this page, the site Disclaimer , as well as the definitions for Patent , Administrative Status , Maintenance Fee  and Payment History  should be consulted.

Administrative Status

Title Date
Forecasted Issue Date Unavailable
(86) PCT Filing Date 2013-03-01
(87) PCT Publication Date 2013-09-12
(85) National Entry 2014-08-26
Dead Application 2019-03-01

Abandonment History

Abandonment Date Reason Reinstatement Date
2018-03-01 FAILURE TO REQUEST EXAMINATION
2018-03-01 FAILURE TO PAY APPLICATION MAINTENANCE FEE

Payment History

Fee Type Anniversary Year Due Date Amount Paid Paid Date
Registration of a document - section 124 $100.00 2014-08-26
Application Fee $400.00 2014-08-26
Maintenance Fee - Application - New Act 2 2015-03-02 $100.00 2014-08-26
Maintenance Fee - Application - New Act 3 2016-03-01 $100.00 2016-02-25
Maintenance Fee - Application - New Act 4 2017-03-01 $100.00 2017-02-22
Owners on Record

Note: Records showing the ownership history in alphabetical order.

Current Owners on Record
GERIGK, ROBERTO
Past Owners on Record
None
Past Owners that do not appear in the "Owners on Record" listing will appear in other documentation within the application.
Documents

To view selected files, please enter reCAPTCHA code :



To view images, click a link in the Document Description column. To download the documents, select one or more checkboxes in the first column and then click the "Download Selected in PDF format (Zip Archive)" or the "Download Selected as Single PDF" button.

List of published and non-published patent-specific documents on the CPD .

If you have any difficulty accessing content, you can call the Client Service Centre at 1-866-997-1936 or send them an e-mail at CIPO Client Service Centre.


Document
Description 
Date
(yyyy-mm-dd) 
Number of pages   Size of Image (KB) 
Cover Page 2014-11-14 1 242
Abstract 2014-08-26 1 236
Claims 2014-08-26 3 83
Drawings 2014-08-26 5 1,749
Description 2014-08-26 38 1,375
Representative Drawing 2014-10-08 1 210
PCT 2014-08-26 6 181
Assignment 2014-08-26 10 316
PCT 2014-10-06 6 212